20 results  1 of 2 

1 Bevacizumab Plus Erlotinib Combination Therapy for Advanced Hereditary Leiomyomatosis and Renal Cell Carcinoma-Associated Renal Cell Carcinoma: A Multicenter Retrospective Analysis in Korean Patients
Yeonjoo Choi, Bhumsuk Keam, Miso Kim, Shinkyo Yoon, Dalyong Kim, Jong Gwon Choi, Ja Young Seo, Inkeun Park, Jae Lyun Lee
Cancer Res Treat.2019;51(4):1549-1556.   Published online 2019 March 25     DOI: http://dx.doi.org/10.4143/crt.2019.086
      
2 The Risk of Herpes Zoster in Patients with Non-small Cell Lung Cancer according to Chemotherapy Regimens: Tyrosine Kinase Inhibitors versus Cytotoxic Chemotherapy
Ji Young Choi, Miso Kim, Bhumsuk Keam, Tae Min Kim, Dong-Wan Kim, Dae Seog Heo, Seong Jin Jo
Cancer Res Treat.2019;51(1):169-177.   Published online 2018 April 5     DOI: http://dx.doi.org/10.4143/crt.2017.491
      
3 Concomitant Statin Use Has a Favorable Effect on Gemcitabine-Erlotinib Combination Chemotherapy for Advanced Pancreatic Cancer
Do Chang Moon, Hee Seung Lee, Yong Il Lee, Moon Jae Chung, Jeong Youp Park, Seung Woo Park, Si Young Song, Jae Bock Chung, Seungmin Bang
Yonsei Med J.2016;57(5):1124-1130.   Published online 2016 June 30     DOI: http://dx.doi.org/10.3349/ymj.2016.57.5.1124
      
4 Successful Treatment with Empirical Erlotinib in a Patient with Respiratory Failure Caused by Extensive Lung Adenocarcinoma
Suk Hyeon Jeong, Sang-Won Um, Hyun Lee, Kyeongman Jeon, Kyung Jong Lee, Gee Young Suh, Man Pyo Chung, Hojoong Kim, O Jung Kwon, Yoon La Choi
Korean J Crit Care Med.2016;31(1):44-48.   Published online 2016 February 29     DOI: http://dx.doi.org/10.4266/kjccm.2016.31.1.44
      
5 Ovarian Metastasis from Non-Small Cell Lung Cancer Responding to Erlotinib
Ik Ju Jung, Seung Taek Lim, Yeon Seok Choi, Tae Soo Jang, Sun Hee Oh, Joo Ah Lee, Do Yeun Cho
Ewha Med J.2015;38(1):46-49.   Published online 2015 March 26     DOI: http://dx.doi.org/10.12771/emj.2015.38.1.46
      
6 Pemetrexed-Erlotinib, Pemetrexed Alone, or Erlotinib Alone as Second-Line Treatment for East Asian and Non-East Asian Never-Smokers with Locally Advanced or Metastatic Nonsquamous Non-small Cell Lung Cancer: Exploratory Subgroup Analysis of a Phase II Trial
Dae Ho Lee, Jung Shin Lee, Jie Wang, Te-Chun Hsia, Xin Wang, Jongseok Kim, Mauro Orlando
Cancer Res Treat.2015;47(4):616-629.   Published online 2014 November 24     DOI: http://dx.doi.org/10.4143/crt.2014.051
      
7 Gemcitabine Combined with Capecitabine Compared to Gemcitabine with or without Erlotinib as First-Line Chemotherapy in Patients with Advanced Pancreatic Cancer
Jae Yun Lim, Jang Ho Cho, Se Joon Lee, Dong Ki Lee, Dong Sup Yoon, Jae Yong Cho
Cancer Res Treat.2015;47(2):266-273.   Published online 2014 August 29     DOI: http://dx.doi.org/10.4143/crt.2013.158
      
8 A Favorable Treatment Response of Erlotinib in Lung Adenocarcinoma with Concomitant Activating EGFR Mutation and ROS1 Rearrangement
Min Hwan Kim, Yehyun Park, Hye Jung Park, Ah-young Ji, Changho Song, Moo-Nyun Jin, Young Ju Kim, Sun Wook Kim, Jung-Hee Lee, In-Soo Kim, Hye Ryun Kim, Joohang Kim, Byoung Chul Cho
Ewha Med J.2014;37(1):46-51.   Published online 2014 March 25     DOI: http://dx.doi.org/10.12771/emj.2014.37.1.46
      
9 Erlotinib Induced Trichomegaly of the Eyelashes
Sang-Hoon Jeon, Jeong-Seon Ryu, Gwang-Seong Choi, Jung-Soo Kim, Hea-Yoon Kwon, Min-Su Kim, Hae-Seong Nam, Jae-Hwa Cho, Seung-Min Kwak, Hong Lyeol Lee, Hyun-Jung Kim, Geun-Jeong Hong
Tuberc Respir Dis.2013;74(1):37-40.   Published online 2013 January 31     DOI: http://dx.doi.org/10.4046/trd.2013.74.1.37
      
10 Bioequivalence of Two Erlotinib Formulations in Healthy Volunteers
JaeWoo Kim, Eun-Heui Jin, Youn-Woong Choi, Byung-Gu Min, Byung-Hoon Lee, Jin-Seong Chung, Kyu-Yeol Nam, Won-Tae Jung, Soo-Hwan Kim, Hye J. Lee, Jang-Hee Hong
J Korean Soc Clin Pharmacol Ther.2013;21(2):159-165.   Published online 2013 January 11     DOI: http://dx.doi.org/10.12793/jkscpt.2013.21.2.159
   
11 A Case of Cicatricial Alopecia Associated with Erlotinib
Bo Hee Yang, Chan Yl Bang, Ji Won Byun, Sung Hyub Han, Hee Jin Song, Seung Gyun In, Jeong Hyun Shin, Gwang Seong Choi
Ann Dermatol.2011;23(Suppl 3):S350-S353.   Published online 2011 December 27     DOI: http://dx.doi.org/10.5021/ad.2011.23.S3.S350
      
12 Black Hairy Tongue Associated with Erlotinib Treatment in a Patient with Advanced Lung Cancer
Jin Seob Jeong, Ji Yeoun Lee, Mi Kyeong Kim, Tae Young Yoon
Ann Dermatol.2011;23(4):526-528.   Published online 2011 November 3     DOI: http://dx.doi.org/10.5021/ad.2011.23.4.526
      
13 Successful Rechallenge with Gefitinib for an Initial Erlotinib-Responder with Advanced Lung Adenocarcinoma
Sung Chul Hong, Yun Su Sim, Jin Hwa Lee, Yon Ju Ryu, Jung Hyun Chang
Tuberc Respir Dis.2011;71(4):286-290.   Published online 2011 October 31     DOI: http://dx.doi.org/10.4046/trd.2011.71.4.286
      
14 Comparison of Therapeutic Efficacy of Gefitinib and Erlotinib in Patients with Squamous Cell Lung Cancer
Hong-Joon Shin, Tae-Ok Kim, Hyun-Wook Kang, Su-Young Chi, Hee-Jung Ban, Soo-Ok Kim, Yong-Soo Kwon, In-Jae Oh, Kyu-Sik Kim, Yu-Il Kim, Sung-Chul Lim, Young-Chul Kim
Tuberc Respir Dis.2011;71(1):15-23.   Published online 2011 July 31     DOI: http://dx.doi.org/10.4046/trd.2011.71.1.15
      
15 Bowel Perforation after Erlotinib Treatment in a Patient with Non-Small Cell Lung Cancer
Yun-Hong Cheon, Moon Jin Kim, Min Gyu Kang, Hee Jin Kim, Sang Su Lee, Cha Young Kim, Dae-Hong Jeon, Yu Eun Kim, Gyeong-Won Lee
Yonsei Med J.2011;52(4):695-698.   Published online 2011 May 21     DOI: http://dx.doi.org/10.3349/ymj.2011.52.4.695
      
16 Erlotinib-Related Spontaneous Pneumothorax in Patient with Primary Lung Cancer
Hae-Seong Nam, Hyeon-Jeong Lee, Min Su Kim, Sung Wook Park, Sang-Hoon Jeon, Jae Hwa Cho, Seung Min Kwak, Hong Lyeol Lee, Jeong-Seon Ryu
Tuberc Respir Dis.2010;69(6):465-468.   Published online 2010 December 31     DOI: http://dx.doi.org/10.4046/trd.2010.69.6.465
      
17 Recurrent Erlotinib-Induced Interstitial Lung Disease on Non-Small Cell Lung Cancer
Sang Don Park, Areum Kim, Jin-Seok Park, Chun Ho Shin, Hae Sung Nam, Lucia Kim, Jae Wha Cho, Jeong Sun Ryu, Seung Min Kwak
Tuberc Respir Dis.2009;67(5):445-448.   Published online 2009 November 30     DOI: http://dx.doi.org/10.4046/trd.2009.67.5.445
      
18 Combining Erlotinib with Cytotoxic Chemotherapy May Overcome Resistance Caused by T790M Mutation of EGFR Gene in Non-Small Cell Lung Carcinoma
In-Jae Oh, Kyu-Sik Kim, Ju-Yeon Jeong, Hyun-Ju Cho, Young-Chul Kim
J Lung Cancer.2009;8(2):92-98.   Published online 2009 January 10     DOI: http://dx.doi.org/10.6058/jlc.2009.8.2.92
   
19 Targeted Therapy of Lung Cancer
Kye Young Lee
J Korean Med Assoc.2008;51(5):483-491.   Published online 2008 May 31     DOI: http://dx.doi.org/10.5124/jkma.2008.51.5.483
      
20 Sequential Responses of Adenocarcinoma of the Lung to Erlotinib after Gefitinib in Never Smoker Korean Woman
Hoon-Kyo Kim, Myeong Im Ahn, Jinyoung Yoo, Chi Hong Kim, Hong-Jun Yang, Byoung Yong Shim
Cancer Res Treat.2007;39(1):37-39.   Published online 2007 March 31     DOI: http://dx.doi.org/10.4143/crt.2007.39.1.37
      

 1 of 2